Masse, Marie-Hélène
Adhikari, Neill K. J.
Théroux, Xavier
Battista, Marie-Claude
D’Aragon, Frédérick
Pinto, Ruxandra
Cohen, Alan
Mayette, Michaël
St-Arnaud, Charles
Kho, Michelle
Chassé, Michaël
Lebrasseur, Martine
Watpool, Irene
Porteous, Rebecca
Wilcox, M. Elizabeth
Lamontagne, François
Article History
Received: 19 August 2021
Accepted: 19 November 2021
First Online: 3 January 2022
Declarations
:
: This study was approved by the Research Ethics Board (REB) at each participating site (CIUSSS de l’Estrie-CHUS REB for the two Quebec sites (#MP-31-2019-3113), Sunnybrook Health Sciences Centre REB (#177–2019), University Health Network REB (#18–6157), Ottawa Hospital Research Institute REB (#1465 20190384-01H)) which waived the need for informed consent for patients identified retrospectivelyPatients enrolled in the OVATION-65 trial provided informed consent. Methods were carried out in accordance with the relevant guidelines and regulations (e.g. the Declaration of Helsinki).
: Not applicable.
: None